Themed "Global IVD Innovation & Cross-Regional Integration," this groundbreaking event brings together distinguished experts from around the world to explore the future of diagnostics.

Labcorp, a leading global life sciences company, today announced results for the fourth quarter and year ended Dec. 31, 2022, full-year 2023 guidance.

Recently, Chongqing Federation of Industry and Commerce released the "Top 100 list of Chongqing Private Enterprises' Science and Technology Innovation Index", and Zybio ranked 3rd on the list.

After issuing Emergency Use Authorizations for more than 400 COVID-19 tests and seven Mpox tests, the US Food and Drug Administration said Wednesday that it is nearing the end of EUA reviews of new in vitro diagnostics.

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, today announced financial results for the fourth quarter and full year ended December 31, 2022.

The biggest tech companies may be facing relatively tough times, but the 25th edition of the Fortune World’s Most Admired Companies All-Stars list suggests that the giants’ peers respect them as much as ever.

The US Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for the Xpert Mpox test from molecular diagnostics company Cepheid.

QuidelOrtho Corporation, a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced financial results for the fourth quarter ended January 1, 2023.

On February 7 2023, RocGene's independently developed Archimed Mini 16 Medical Fluorescence Quantitative PCR Instrument obtained the Class III Medical Device Registration Certificate by the National Medical Products Administration.

QIAGEN N.V. today announced the certification of QuantiFERON-TB Gold Plus (QFT-Plus) – the world’s leading tuberculosis (TB) blood test – under the European Union’s 2017/746 In Vitro Diagnostic Medical Devices Regulation (IVDR) which is replacing the 98/79/EC In Vitro Diagnostic Directive (IVDD).

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today reported financial results for the fourth quarter and full year ended January 1, 2023.